CHO Pharma, Inc. (TPEX: 6586)
Taiwan
· Delayed Price · Currency is TWD 51.90
-1.70 (-3.17%)
Dec 20, 2024, 2:59 PM CST
CHO Pharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -255.25 | -306.09 | -338.39 | -205.93 | -296.84 | -358.37 | Upgrade
|
| Depreciation & Amortization | 26.56 | 28.28 | 39.85 | 39.08 | 41.24 | 34.05 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.09 | 1.24 | Upgrade
|
| Asset Writedown & Restructuring Costs | 52.73 | 52.73 | - | 6 | - | - | Upgrade
|
| Stock-Based Compensation | -5.9 | -7.66 | 21.99 | -13.84 | -5.02 | 1.02 | Upgrade
|
| Other Operating Activities | -3.29 | -2 | -0.01 | 0 | 0.01 | -0.03 | Upgrade
|
| Change in Accounts Receivable | -0.42 | - | 0.06 | -0.06 | - | - | Upgrade
|
| Change in Accounts Payable | -54.38 | -52.68 | 38.24 | -16.47 | 14.61 | 57.41 | Upgrade
|
| Change in Other Net Operating Assets | -5.49 | -3.71 | -11.24 | -2.26 | -2.81 | -2.04 | Upgrade
|
| Operating Cash Flow | -245.44 | -291.13 | -249.5 | -193.47 | -248.73 | -266.72 | Upgrade
|
| Capital Expenditures | -4.85 | -2 | -9.4 | -2.64 | -19.16 | -11.44 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -3 | - | Upgrade
|
| Investment in Securities | -1,833 | -1,860 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | 2.57 | 0.39 | -0.39 | 3.12 | -5.43 | Upgrade
|
| Investing Cash Flow | -1,838 | -1,859 | -9.01 | -3.03 | -19.04 | -16.86 | Upgrade
|
| Long-Term Debt Repaid | - | -11.7 | -14.4 | -12.52 | -12.24 | -4.98 | Upgrade
|
| Net Debt Issued (Repaid) | -12.86 | -11.7 | -14.4 | -12.52 | -12.24 | -4.98 | Upgrade
|
| Issuance of Common Stock | 1,860 | 1,860 | 0.5 | 1.21 | 2.65 | 13.79 | Upgrade
|
| Financing Cash Flow | 1,847 | 1,849 | -13.9 | -11.31 | -9.59 | 8.81 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.07 | 0.05 | 0.09 | -0.6 | -0.71 | -1.87 | Upgrade
|
| Net Cash Flow | -235.73 | -301.87 | -272.33 | -208.41 | -278.07 | -276.63 | Upgrade
|
| Free Cash Flow | -250.29 | -293.13 | -258.9 | -196.11 | -267.89 | -278.15 | Upgrade
|
| Free Cash Flow Margin | -23132.16% | - | -431501.67% | -5493.25% | -194121.74% | -93653.87% | Upgrade
|
| Free Cash Flow Per Share | -1.21 | -1.53 | -1.41 | -1.07 | -1.46 | -1.52 | Upgrade
|
| Cash Interest Paid | 0.39 | 0.08 | 0.3 | 0.58 | 0.78 | 0.4 | Upgrade
|
| Cash Income Tax Paid | 1.84 | 0.46 | 0.01 | - | -0.01 | -0.02 | Upgrade
|
| Levered Free Cash Flow | -192.7 | -206.15 | -140.34 | -128.96 | -168.26 | -150.89 | Upgrade
|
| Unlevered Free Cash Flow | -192.45 | -206.1 | -140.15 | -128.6 | -167.78 | -150.64 | Upgrade
|
| Change in Net Working Capital | 63.39 | 56.6 | -26.72 | 19.65 | -11.63 | -56.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.